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Synopsis 16 
Objective 17 
To elucidate how population trends in total antimicrobials dispensed in the community translate into 18 
individual exposure.  19 
Methods 20 
Retrospective, population-based observational study of all antimicrobial prescribing in a Scottish region 21 
in financial years 1995, 2000 and 2005-2014. Analysis of temporal changes in all antimicrobials and 22 
specific antimicrobials measured in: WHO DDD per 1000 population; prescriptions per 1000 population; 23 
proportion of population with ≥1 prescription; mean number of prescriptions per person receiving any; 24 
mean DDD per prescription.  25 
Results 26 
Antimicrobial DDD increased between 1995 and 2014, from 5651 to 6987 per 1000 population 27 
(difference 1336 (95%CI 1309 to 1363)). Prescriptions per 1000 fell (from 821 to 667, difference -154, -28 
151 to -157), as did the proportion prescribed any antimicrobial (from 39.3% to 30.8% (-8.5, -8.4 to -29 
8.6)). Rising mean DDD per prescription, from 6.88 in 1995 to 10.47 in 2014 (3.59, 3.55 to 3.63), drove 30 
rising total DDD. In the under-5s, every measure fell over time (68.2% fall in DDD per 1000; 60.7% fall in 31 
prescriptions per1000). Among 5-64 year olds, prescriptions per1000 was lowest in 2014 but among 32 
older people, despite a reduction since 2010, the 2014 rate was still higher than in 2000. Trends in 33 
individual antimicrobials provide some explanation for overall trends.  34 
Conclusion 35 
Rising antimicrobial volumes up to 2011 were mainly due to rising DDD per prescription. Trends in 36 
dispensed drug volumes do not readily translate into information on individual exposure which is more 37 
relevant for adverse consequences including emergence of resistance.   38 
Introduction 39 
Antimicrobial resistance (AMR) is a global public health threat with antimicrobial use in humans 40 
significantly contributing.1-3 Approximately 80% of UK antimicrobial use is in the community, with up to 41 
50% deemed inappropriate.1 Associations between primary care prescribing and AMR are well 42 
described,1, 4-7 and multiple initiatives have targeted reductions in this prescribing,2, 3, 8-10 but UK rates 43 
appeared to still be increasing until 2012.11, 12 This interpretation is based on population-level volumes of 44 
antimicrobials dispensed, measured in WHO Collaborating Centre for Drug Statistics Methodology’s 45 
DDD.13 DDD is the assumed average maintenance dose per day for an individual drug’s main indication 46 
in adults rather than the actual daily dose used in practice which has changed over time, as has the mix 47 
of antimicrobials used which also affects total DDD.13  48 
Increases in total DDD could be due to more people being prescribed, more prescriptions for each 49 
person, and/or changes in antimicrobial choice or dose. Therefore, total DDD can change without 50 
changes in the proportion of the population exposed. Measures other than total DDD are required to 51 
examine antimicrobial use and the impact of antimicrobial stewardship interventions,14 and changes 52 
within specific patient groups and antimicrobials could help explain population changes. In this study, 53 
we examined changes in primary care antimicrobial use from 1995 to 2014 in Tayside, Scotland, using 54 
patient-level data for all community dispensed antimicrobials across a complete geographical 55 
population.  56 
Population and methods 57 
The Tayside region of Scotland has a stable population with health care delivered by a single National 58 
Health Service (NHS) organisation. Access to NHS services requires registration with a single general 59 
practice which delivers all primary health care including prescribing.  60 
The Health Informatics Centre (HIC),15 University of Dundee, enables anonymised linkage of health and 61 
demographic data from multiple population datasets in NHS Tayside at the individual patient level, via a 62 
unique identifier (the community health index (CHI) number) used across all healthcare delivery in 63 
Scotland. We linked demographic data on everyone registered with a Tayside general practice to 64 
dispensed primary care prescriptions for oral antimicrobials for financial years 1995, 2000 and 2005-65 
2014. Annual measurements were in financial years (e.g. 2005 is 1st April 2005 to 31st March 2006) so 66 
each year included a complete winter. HIC provided annual population estimates by age and gender. We 67 
calculated the DDD for each prescription using 2014 values.13 Data allowing DDD calculation (either/both 68 
of strength or quantity) were missing from 0.8% of prescriptions (highest in earlier years) so we used 69 
multiple imputation to estimate missing DDD values, with age, gender, drug and year of prescription as 70 
predictors. Antimicrobials were grouped into classes as defined in the British National Formulary version 71 
68 chapter 5 (penicillins, tetracyclines, macrolides, sulphonamides and trimethoprim, quinolones, 72 
metronidazole and tinidazole, cephalosporins, other).16 73 
We calculated antimicrobial DDD and prescriptions dispensed per 1000 population per year, in total, by 74 
class, and by age group (<5 years old; 5-64 years old; >64 years old). We then calculated the proportion 75 
of the population with at least one prescription in each study year, the mean and median number of 76 
prescriptions per patient per year among patients with any antimicrobial prescription in that year, and 77 
the mean and median DDD per prescription in each year, in total and by age group and gender. 78 
Statistical comparisons between 2014 and 1995 used chi-squared tests for proportions, Student’s t-test 79 
for means, and Mann –Whitney U test for medians. Statistical tests of trend for total DDD and total 80 
prescriptions, both per 1000 population per year, included the continuous data period (2005 to 2014). 81 
The large dataset means that statistical tests of significance should be interpreted alongside clinical 82 
significance. 83 
 84 
To estimate the extent to which changes in total DDD and total prescriptions, per 1000 population, were 85 
attributable to changes in each contributory measure (patients per 1000 population with any 86 
prescription, mean prescriptions per patient with any, mean DDD per prescription) we calculated the 87 
relative (percentage) change in each measure for each year compared to 1995.  88 
To investigate potential reasons behind any changes we first examined seasonal variation in prescribing, 89 
which is attributed to prescribing for respiratory tract infection. Seasonal variation, using DDD, is a 90 
European Surveillance of Antimicrobial Consumption (ESAC) quality indicator.17, 18 We calculated 91 
prescriptions per 1000 population quarterly by age group and expressed seasonal variation as overuse in 92 
“winter” quarters (October-March) compared to the previous “summer” quarters (April-September) as a 93 
percentage, and compared 2014 to 1995 using chi-squared tests. We then examined trends in 94 
prescribing, from 2005-2014, of twelve commonly prescribed individual antimicrobial drugs (amoxicillin, 95 
ciprofloxacin, clarithromycin, co-amoxiclav, doxycycline, erythromycin, flucloxacillin, lymecycline, 96 
nitrofurantoin, oxyetracycline, penicillin V, trimethoprim).  97 
 Anonymised record linkage was conducted in accordance with HIC Standard Operating Procedures 98 
(SOP).15 These are approved by The East of Scotland Research Ethics Service and the NHS Tayside 99 
Caldicott Guardian with agreement that studies adhering to the SOP do not require individual ethical 100 
review. All data were analysed in IBM SPSS statistics v22 in an ISO27001 and Scottish Government 101 
accredited data Safe Haven. 102 
Results  103 
In 1995 and 2014 there were 419,447 and 441,298 registered patients, respectively. 49% were male. In 104 
all study years 5% were under 5 years old, but the proportion >64 years increased from 16% to 20%. 105 
2,377,258 antimicrobial DDD were dispensed in 1995, rising to 3,083,451 in 2014, but prescriptions fell 106 
from 345,328 to 294,391, and the proportion of the population exposed fell from 39% to 31%. 107 
DDD per 1000 population 108 
Among the whole population, DDD per 1000 population fell between 1995 and 2000 then increased to a 109 
peak at 7092 in 2011 before decreasing to 6987 in 2014 (Table 1, Figure 1). There was a very large (68%) 110 
reduction among those <5 but increases otherwise (Table 1). Change varied by antimicrobial class 111 
(Figure 1), with more than doubling of tetracycline DDD per 1000 population per year between 1995 and 112 
2014 (18% versus 31% of total DDD), and increases in all other classes except cephalosporins (7% versus 113 
0.5%) and quinolones (4% versus 2%) (Figure 1, Table S1).  114 
Prescriptions per 1000 population 115 
Antimicrobial prescriptions per 1000 population overall fell between 1995 and 2000 then increased until 116 
2011 before falling to 667 by 2014 (Table 1, Figure 2). There was a large (61%) reduction among those 117 
<5s and a small (2%) increase among those >64 (Table 1). Seasonal variation was greatest among pre-118 
school children (Figure 3) with 52-69% more prescriptions per 1000 population each winter, except in 119 
2007 (40%) due to low winter prescribing, and no significant difference between 1995 and 2014 (chi2 120 
test p=0.92). Seasonal variation in other age groups decreased over time, from 29% among 5-64yr olds 121 
and 25% among those >64 in 1995, to 5% and 6% in 2014, respectively (chi2 tests p <0.001).  122 
Changes by antimicrobial class were similar to DDD, with reductions in cephalosporins (from 9% to 1% of 123 
prescriptions) and quinolones (4% to 2%), and increases in tetracyclines (10% to 17%) and 124 
sulphonamides/trimethoprim (7% to 12%) (Figure 2, Table S1). 125 
Proportion prescribed any antimicrobial 126 
The proportion of the population with at least one antimicrobial prescription per year fell overall. There 127 
was a reduction from 1995 to 2000, followed by increases between 2005 and 2012, then a reduction to 128 
308 per 1000 population by 2014 (Tables 1 and 2). The biggest reductions were among those <5, who 129 
had the highest rate until 2005. Older people had the highest rate since then, but this reduced from 445 130 
to 412 per 1000 population between 2010 and 2014. Among 5-64 year olds, there was a 24% reduction 131 
overall (Table 1). Higher proportions of females (11-13% difference) had prescriptions each year but 132 
without temporal trend in differences (45% versus 33% in 1995; 37% versus 25% in 2014). Gender 133 
difference was largest among 5-64 year olds (females 13-15% higher each year). Among those <5 more 134 
males (1-3% higher each year) had any prescription (Table S2). 135 
Prescriptions per patient dispensed at least one antimicrobial 136 
In 1995, the 164,864 people in Tayside with at least one antimicrobial prescription had a mean 2.09 137 
prescriptions. Overall, there were clinically small but statistically significant changes over time, with 138 
increases since 2000 resulting in patients with any prescription in 2014 receiving a mean additional 0.08 139 
prescriptions compared to 1995. There were reductions among pre-school children and increases among 140 
older people (Table 1). Females with any prescription had higher mean prescriptions, overall (mean 141 
additional 0.19-0.28 prescriptions per patient per year), among 5-64 year olds (additional 0.20-0.28) and 142 
those over 64 years (additional 0.15-0.36), but among those <5 this was higher for males (additional 143 
0.00-0.12). The gender difference among those >65 increased over time but there were no other 144 
temporal patterns (Table S2).   145 
Median prescriptions per patient with any per year was 1.00 except among those >64, and those <5 in 146 
1995 only, with median 2.00 (Table 1). 147 
DDD per prescription 148 
Mean DDD per prescription overall increased by more than half over the study period (Table 1, Table 2). 149 
Among young children it was low (due to paediatric dosing) and decreased by 0.72 (95% CI -0.66 to -150 
0.80) while it increased among 5-64 year olds by 4.00 (3.95 to 4.06) (Table 1). Males had higher mean 151 
DDD per prescription overall, and the difference increased over time, from 0.69 additional DDD per 152 
prescription in 1995 to 2.28 in 2014. The difference among those <5 decreased with time; males having 153 
an additional 0.23 in 1995 but females having an additional 0.05 by 2014 (Table S2). 154 
 155 
Median DDD per prescription was 2.50 in all years among those <5, but it increased from 5.25 in 1995 156 
for others to 7.50 among those aged 5-64 years and 8.00 among those >64 by 2014 (Table 1).  157 
Among most antimicrobial drug classes mean DDD per prescription increased: penicillins from 5.60 to 158 
8.64; tetracyclines from 12.87 to 18.88; quinolones from 7.15 to 11.23; macrolides 8.51 to 15.44. 159 
Cephalosporin mean DDD was more constant (4.54 and4.87) and the mean DDD per 160 
sulphonamide/trimethoprim prescription decreased from 7.69 in 1995 to 5.77 in 2014. 161 
Contribution to changes in aggregate measures 162 
Total antimicrobial DDD per 1000 population was 24% higher in 2014 than in 1995 despite prescriptions 163 
per 1000 population decreasing by 19% (Table 2). Of potentially contributory measures, the proportion 164 
of the population with any prescription fell continuously and although mean prescriptions per patient 165 
increased until 2011, the changes are numerically small and decreased slightly by 2014 (Table 2). 166 
Changes in this measure only account for 10,455 (3.6%) prescriptions dispensed in 2014. In contrast, the 167 
mean DDD per prescription increased by 52.2% between 1995 and 2014 (Table 2). Had the mean DDD 168 
per prescription not changed, total DDD in 2014 would have been 2,025,410 (rather than the observed 169 
3,083,451), a 19% reduction in DDD per 1000 population from 1995, rather than the observed 24% 170 
increase.  171 
Trends in individual drugs 172 
Amoxicillin had the highest DDD and prescriptions per 1000 population of any individual drug and both 173 
increased until 2011 then fell until 2014 (Figure 4, Table S3). The converging trend lines for DDD and 174 
prescriptions per 1000 population reflect the increasing DDD per prescription (Figure 4). Other 175 
penicillins (co-amoxiclav, flucloxacillin and penicillin V) also had increasing DDD per prescription, and 176 
reducing prescriptions per 1000 population (Figure 4). Drugs targeted by a 2008 Tayside antimicrobial 177 
stewardship intervention (ciprofloxacin and co-amoxiclav)19 had reducing DDD and prescriptions per 178 
1000 population since 2008, while drugs recommended in the intervention guidelines (doxycycline, 179 
nitrofurantoin and trimethoprim)19 had increasing DDD and prescriptions per 1000 population but 180 
reducing DDD per prescription (Figure 4). Clarithromycin and erythromycin had high mean DDD per 181 
prescription, with small increases over time (Figure 4). Lymecycline and oxytetracycline have very high 182 
mean DDD per prescription (>28 at each time point, Figure 4), reflecting long term use for acne, and 183 
resulting in disproportionate contributions to total DDD per 1000 population for a relatively small 184 
number of patients (Figure 4, Table S3). 185 
Discussion  186 
Summary  187 
In this large population based study with individual prescribing data we found that antimicrobial use in 188 
DDD increased considerably between 1995 and 2014 in Tayside, despite substantial reductions in 189 
prescriptions per 1000 residents and the proportion of the population exposed. Between 2000 and 2011 190 
there were annual increases in total prescriptions, the proportion of the population exposed, and mean 191 
prescriptions per patient, but total prescriptions and the proportion exposed then fell again and had 192 
returned to the same level as 2000, or lower, by 2014. Among pre-school children (<5 years old) 193 
antimicrobial use by all measures decreased substantially, but among older people (>64 years old) all 194 
measures were the same or higher, except the proportion exposed, which had decreased by 7%. 195 
Seasonal variation, representing prescribing for respiratory tract infection, reduced overall but remained 196 
high among pre-school children. The most significant change in prescribing practice was the large 197 
increase in mean DDD per prescription, which was driven by both increasing doses (e.g. penicillins and 198 
macrolides) and changes in choice of antimicrobial (e.g. greater use of doxycycline).  199 
Strengths and Limitations 200 
We report secular trends across a comprehensive set of antimicrobial prescribing measures using 201 
patient-level dispensed prescribing data across a whole geographical population. Most previous reports 202 
generally focus on volume (e.g. DDD) and/or prescriptions (or packages) per 1000 population, or 203 
patient-level analysis for specific clinical conditions.20-26 A recent, more comprehensive, study included 204 
data across a whole country but without demographic information and included only seven years’ 205 
data.14 Our ability to link demographic and detailed prescribing data at patient level, including 206 
historically, enabled detailed investigation over a relatively long time period.  207 
The limitations of this study include those common to observational studies using routine data, such as 208 
potentially incomplete data. We addressed missing DDD data using multiple imputation. Consistent with 209 
successful imputation, the mean DDD per prescription was almost identical afterwards. A further 210 
limitation is the lack of prescribing indication data, but coding in GP records is not reliably consistent 211 
between practices or over time. In our analysis of 12 individual drugs, prescriptions per 1000 population 212 
of trimethoprim and nitrofurantoin, both used almost exclusively for urinary tract infections (UTI) in NHS 213 
Tayside, increased after a stewardship intervention which promoted these drugs,19 then levelled off 214 
since 2011 (Figure 4). The decreasing mean DDD per prescription is consistent with recommended short-215 
course treatment for uncomplicated UTI.27 The proportion of nitrofurantoin and trimethoprim 216 
prescriptions for women aged 16 to 64 years for three-days or less (≤0.6 grams nitrofurantoin; ≤1.2 217 
grams trimethoprim), increased from 0.5% to 31.5%, and 13.1% to 59.9%, respectively, between 1995 218 
and 2014. Reductions in trends of amoxicillin and doxycycline prescriptions since 2011/2012, without 219 
increases in other drugs used for respiratory tract infections (Figure 4), suggest reductions in prescribing 220 
for this indication recently.   221 
While we cannot assume similar changes in patient-level prescribing explain trends in DDD elsewhere, 222 
the observed reductions in cephalosporin and fluoroquinolone use and increases in tetracycline use are 223 
consistent with national guideline changes,19, 28 and we know that cephalosporins, co-amoxiclav and 224 
fluoroquinolones, as a proportion of all community prescriptions, have reduced across Scotland and in 225 
England.12, 29 These intended changes contributed to observed increases in DDD due to promoted drugs 226 
such as doxycycline having a relatively low DDD value. Changes in recommended dosing additionally 227 
contributed to the observed increased DDD per prescription. Local guideline recommended amoxicillin 228 
doses for non-severe community acquired pneumonia increased from 500mg to 1g three times daily in 229 
2009,28, 30 and the increasing amoxicillin DDD per prescription is consistent with this guideline 230 
influencing dosing. Similar trends in dosing impacting on DDD per treatment have occurred elsewhere,14 231 
indicating our findings will apply more widely. 232 
Comparison with other data 233 
The observed increase in total antimicrobial DDD until 2011 is consistent with other reports of primary 234 
care antimicrobial use,11, 14, 31-34 with many developed countries reporting reductions in the 1990s and 235 
increases between 2000 and 2010.9, 12, 35, 36 Compared to primary care data from all Scotland and from 236 
England, Tayside had lower DDD per 1000 population in 2010 (Tayside 19.3 DDD per 1000 population 237 
per day, Scotland 20.1, England 20.6) but higher rates than England by 2014 (19.1 versus 17.5).12, 37, 38 238 
Tayside had a bigger reduction in antimicrobial prescriptions between 2011 and 2014, falling from 2.06 239 
to 1.83 per 1000 population per day, than Scotland (2.14 to 2.05),12 England (1.92 both years),39 Wales 240 
(2.32 to 2.30)40 and Northern Ireland (2.90 to 2.84).41 National reports have limited adjustment for 241 
population demographics with the exception is the “STAR-PU” (Specific Therapeutic group Age-sex 242 
weightings Related Prescribing Units) English prescribing indicator,29 which provides useful adjusted 243 
trends over time but limited external comparison.  244 
Two large European studies analysing antimicrobial prescribing data up to 2007, reported different 245 
trends when measuring using DDD versus packages per 1000 population,22, 36 and one reported rising 246 
DDD per package (0.04-0.31 DDD increase/package/year), similar to our findings.22 A Belgian study 247 
reported increases in antimicrobial DDD but decreases in antimicrobial packages, treatments and the 248 
proportion of people exposed from 2002-2009 using a variety of measure definitions (rates per 1000 249 
population, per 1000 insured patients, per 1000 GP contacts).14 None of these studies reported 250 
prescribing measures by age or gender of patients exposed, or for individual antimicrobial drugs, which 251 
we found help explain trends in the overall measures. 252 
Between 1994 and 2000, reductions of 45% in the proportion of patients with respiratory tract 253 
infections prescribed antimicrobials, and 27% in total prescriptions per 1000 registered patients, were 254 
reported across 108 UK general practices.20 Similarly, reductions in total antimicrobial prescriptions and 255 
prescriptions for upper respiratory tract infection, adjusted for patient, practitioner and comorbidity, 256 
per 100 patient encounters, were reported between 1991 and 2003 across 495 Australian GPs.26. In 257 
contrast, across 570 UK general practices, a 29% increase in the proportion of cough/cold consultations 258 
with an antimicrobial prescription was observed between 1995 and 2011.24 Consultations coded as 259 
cough/cold increased and the authors attributed between-practice variation to varying concordance 260 
with antimicrobial stewardship,24 but could be due to coding.  261 
Implications 262 
Our results demonstrate that the main factor influencing total antimicrobial DDD in Tayside is DDD per 263 
prescription. Total volume in DDD does not reliably represent actual antimicrobial use so 264 
prescriptions/packages per 1000 population and the proportion of the population exposed better 265 
evaluate changes over time and the impact of stewardship interventions. What this means for the 266 
impact on emerging antimicrobial resistance is not clear, but a recent study modelling relationships 267 
between use and resistance found different associations if use was measured in DDD versus packages.21  268 
However, following reductions in antimicrobial use in all age groups between 1995 and 2000, we 269 
observed increases in most measures between 2000 and 2011, with the exception of preschool children. 270 
In the last few years of observation there were reductions across several measures, but achieving 271 
substantial and sustained reductions in the proportion of the population exposed remains challenging 272 
for antimicrobial stewardship globally.9 National and local antimicrobial stewardship activity in Scotland, 273 
particularly since the formation of the Scottish Antimicrobial Prescribing Group in 2008, has led to 274 
changes in choice of antimicrobial (Figures 1, 2 and 4)9, 12, 19 but there is less impact on total prescribing 275 
within our study timeframe. Older people appear an obvious target group for stewardship due to high 276 
rates of exposure and higher risk of adverse events like Clostridium difficile infection.42 However, for 277 
lower respiratory tract infections, the number needed to treat to prevent serious complications is lower 278 
in older people,43 making reductions challenging. Prescribing rates are lower among those aged 5-64 279 
years but they received 62% of all antimicrobial prescriptions in Tayside in 2014. They may be a better 280 
target for stewardship, with greater scope for change. Recent data from >600 general practices found 281 
minor increases in treatable respiratory tract infections associated with large reductions in antimicrobial 282 
prescribing, but the authors acknowledged the need for analysis in high-risk subgroups.44  283 
Conclusion 284 
Our findings highlight the importance of studying trends in antimicrobial use in greater detail than total 285 
volume in DDD. With antimicrobial stewardship focusing on reducing total prescribing, we need to 286 
replicate the large reductions observed in the 1990s, building on the small reductions since 2011, and to 287 
learn from continued reductions among pre-school children. Further research is required to better 288 
understand the relationship between antimicrobial consumption and resistance and the relative 289 
importance of individual and community exposure.  290 
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Tables 413 
Table 1. Summary of antimicrobial prescribing measures by year and age group among all patients 414 
registered with a general practice in the Tayside NHS Health Board region 415 
 
1995 2000 2005 2010 2014 
Difference (95% CI) 2014 vs 
1995 and p-value# 
< 5 years       
Total number of patients^ 23,054 21,695 19,826 21,266 21,472  
DDD per 1000 patients 6125 2875 2666 2258 1948 -4177 (-4094 to -4260) p<0.001 
Prescriptions per 1000 patients 1612 930 898 776 634 -978 (-956 to -1000) p< 0.001 
Patients per 1000 with prescription 686 487 477 435 367 -319 (-309 to -329) p< 0.001 
Mean prescriptions per patient* 2.44 1.97 1.93 1.83 1.70 -0.74 (-0.79 to -0.69) p<0.001 
Median prescriptions per patient* 2.00 1.00 1.00 1.00 1.00 -1.00 p<0.001~ 
Mean DDD per prescription 3.80 3.09 2.97 2.91 3.08 -0.72 (-0.66 to -0.80) p<0.001 
Median DDD per prescription 2.50 2.50 2.50 2.50 2.50 0 p<0.001 
5 to 64 years       
Total number of patients^ 328,048 322,648 318,200 338,033 332,417  
DDD per 1000 patients 5082 4581 5598 6304 6123 1041 (1014 to 1068) p<0.001 
Prescriptions per 1000 patients 709 563 633 635 548 -161 (-158 to -164) p<0.001 
Patients per 1000 with prescription 362 300 329 322 276 -86 (-84 to -88) p<0.001 
Mean prescriptions per patient* 1.96 1.88 1.92 1.98 1.98 0.02 (0.03 to 0.01) p<0.001 
Median prescriptions per patient* 1.00 1.00 1.00 1.00 1.00 0 p<0.001~ 
Mean DDD per prescription 7.17 8.13 8.85 9.92 11.17 4.00 (3.95 to 4.06) p<0.001 
Median DDD per prescription 5.25 5.25 7.00 7.00 7.50 2.25 p<0.001 
> 64 years        
Total number of patients^ 68,345 69,443 71,211 78,274 87,408  
DDD per 1000 patients 8336 8183 9617 11,523 11,510 3174 (3075 to 3273) p<0.001 
Prescriptions per 1000 patients 1107 1044 1138 1239 1127 20 (9 to 31) p<0.001 
Patients per 1000 with prescription 445 414 443 445 412 -33 (-29 to -37) p<0.001 
Mean prescriptions per patient* 2.45 2.50 2.54 2.76 2.76  0.28 (0.24 to 0.32) p<0.001 
Median prescriptions per patient* 2.00 2.00 2.00 2.00 2.00 0 p<0.001~ 
Mean DDD per prescription 7.53 7.84 8.45 9.30 10.21 2.68 (2.61 to 2.76) 
Median DDD per prescription 5.25 7.00 7.00 7.00 8.00 2.75 p<0.001 
All ages       
Total number of patients^ 419,447 413,786 409,237 437,573 441,298  
DDD per 1000 patients 5651 5094 6153 7037 6987 1336 (1309 to 1363) p<0.001 
Prescriptions per 1000 patients 821 663 733 750 667 -154 (-151 to -157) p<0.001 
Patients per 1000 with prescription 393 329 356 349 308 -85 (-84 to -86) p<0.001 
Mean prescriptions per patient* 2.09 2.02 2.06 2.15 2.17 0.08 (0.06 to 0.09) p<0.001 
Median prescriptions per patient* 1.00 1.00 1.00 1.00 1.00 0 p<0.001~ 
Mean DDD per prescription 6.88 7.68 8.39 9.38 10.47 3.59 (3.55 to 3.63) p<0.001 
Median DDD per prescription 5.25 5.25 7.00 7.00 7.50 2.25 p<0.001 
^ Total patients registered with general practitioner in the region 416 
* Mean and median prescriptions per patient dispensed at least one antimicrobial 417 
~Although there is no numerical difference there is a statistically significant difference in the distribution 418 
# Differences in proportions evaluated using chi-squared, in means using t-test, and in medians using Mann-419 
Whitney U test 420 
Table 2 Percentage change per year compared to 1995 for each measure of antimicrobial prescribing among all registered patients in Tayside 
  Relative (%) change from 1995 value* 
Measure of 
community 
antimicrobial 
prescribing 
Value in 
reference 
year 
1995 
2000 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
Patients per 1000 
with any prescription  
(A) 
393 -16.3 -9.3 -10.2 -11.0 -9.3 -11.9 -11.2 -12.4 -15.5 -19.6 -21.6 
Mean prescriptions 
per patient with any 
(B) 
2.09 -3.3 -1.4 -1.0 1.0 1.4 2.9 2.9 4.8 4.6 4.6 3.8 
Mean DDD per 
prescription  
(C) 
6.88 11.6 21.9 24.2 26.8 29.6 32.6 36.3 39.2 44.0 47.2 52.2 
Prescriptions per 
1000 patients 
(A x B) 
821 -19.1 -10.6 -11.0 -10.2 -8.0 -9.4 -8.6 -8.2 -12.9 -15.8 -18.8 
DDD per 1000 
patients 
(A x B x C) 
5651 -9.7 8.9 10.5 13.9 19.2 20.2 24.6 27.8 27.5 24.0 23.6 
*Positive values are increases, negative values are decreases 
Figures 
Figure 1 Total WHO DDD of antimicrobials dispensed per 1000 registered patients in Tayside per 
financial year (April to March) 
 
Test for trend from 2005-2014: β= 109.99 (R2 = 0.764, p = 0.001) 
  
Figure 2 Total prescriptions dispensed per 1000 registered patients in Tayside per financial year (April to 
March) 
 
 
Test for trend from 2005-2014: β = -5.75 (R2 = 0.366, p = 0.064) 
 
  
Figure 3 Quarterly prescriptions per 1000 registered patients in Tayside by age group in financial years 
(April to March) 2005-14 
 
 
 
Figure 4 Trends in use of twelve individual antimicrobial drugs commonly used in primary care in Tayside, from 2005 to 2014, with use measured in DDD per 1000 
population (dashed lines, left y axes), prescriptions per 1000 population (solid lines, right y axes) and mean DDD per prescription (text below x axes). Each graph is plotted 
on the same scale for ease of comparison. 
 
    
    
    
